Literature DB >> 13164256

[Reliable accomplishment of the two-stage methods in blood coagulation].

P DE NICOLA.   

Abstract

Entities:  

Keywords:  BLOOD COAGULATION; PROTHROMBIN/determination; THROMBIN

Mesh:

Substances:

Year:  1954        PMID: 13164256     DOI: 10.1007/BF01468149

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  16 in total

1.  Research of the new clotting factors.

Authors:  P DE NICOLA
Journal:  Tex Rep Biol Med       Date:  1953

2.  Physiopathological classification of the haemorrhagic diseases.

Authors:  P DE NICOLA
Journal:  Can Med Assoc J       Date:  1952-12       Impact factor: 8.262

3.  [Quantitative relationship between clotting factors V and VII in prothrombin conversion].

Authors:  S WITTE; P DIRNBERGER
Journal:  Acta Haematol       Date:  1953-06       Impact factor: 2.195

4.  Plasma accelerator globulin; partial purification, quantitative determination, and properties.

Authors:  A G WARE; W H SEEGERS
Journal:  J Biol Chem       Date:  1948-02       Impact factor: 5.157

5.  Two-stage procedure for the quantitative determination of prothrombin concentration.

Authors:  A G WARE; W H SEEGERS
Journal:  Am J Clin Pathol       Date:  1949-05       Impact factor: 2.493

6.  Experiments on a new clotting factor (factor VII).

Authors:  F KOLLER; A LOELIGER; F DUCKERT
Journal:  Acta Haematol       Date:  1951       Impact factor: 2.195

7.  The determination of prothrombin (two-stage method) and antithrombin using commercially available reagents.

Authors:  M HURN; F D MANN
Journal:  Am J Clin Pathol       Date:  1947-09       Impact factor: 2.493

8.  The nature of plasma antithrombin activity.

Authors:  P D KLEIN; W H SEEGERS
Journal:  Blood       Date:  1950-08       Impact factor: 22.113

9.  Dicumarol therapy controlled by the stabilized thrombin method for determination of prothrombin.

Authors:  L A STERNBERGER
Journal:  Blood       Date:  1949-10       Impact factor: 22.113

10.  Studies on prothrombin; purification, inactivation with thrombin, and activation with thromboplastin and calcium.

Authors:  A G WARE; W H SEEGERS
Journal:  J Biol Chem       Date:  1948-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.